Merck And Co Inc Drug Patent Portfolio

Merck And Co Inc's Family Patents


Family Patents



Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Merck And Co Inc News

Merck projects 2026 revenue to fall short of expectations due to patent expirations - The Globe and Mail

03 Feb, 2026

Merck exceeds quarterly projections and provides conservative guidance for 2026 amid impending generic competition.

03 Feb, 2026

Merck exceeds Q4 profit forecasts but provides a less optimistic outlook for 2026 - TradingView

03 Feb, 2026

Merck projects 2026 revenue to fall short of expectations due to patent expirations | WKZO | Everything Kalamazoo

03 Feb, 2026

See More